[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2003/96841,2003,A1
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2003/96841,2003,A1
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2003/96841,2003,A1
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO;SUMITOMOCHEMICALCOMPANYLIMITED;SumitomoPharma(in:SumitomoChemical);SumitomoChemical(w/oDongwooFine-Chem)-US2007/49618,2007,A1Locationinpatent:Page/Pagecolumn60-61
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO;SUMITOMOCHEMICALCOMPANYLIMITED;SumitomoPharma(in:SumitomoChemical);SumitomoChemical(w/oDongwooFine-Chem)-US2007/49618,2007,A1Locationinpatent:Page/Pagecolumn57
Title: Scheepstra M, et al. Bivalent Ligands for Protein Degradation in Drug Discovery. Comput Struct Biotechnol J. 2019;17:160-176. Published 2019 Jan 25.
Title: Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-985.